Why did Lil­ly give tirzepatide a new name for obe­si­ty? Hint: It’s the mar­ket­ing

Eli Lil­ly’s de­ci­sion to give two dis­tinc­tive brand names to tirzepatide, which is ap­proved for type 2 di­a­betes and now chron­ic weight man­age­ment, in­di­cates just …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.